BioRestorative Therapies (BRTX) Accumulated Depreciation & Amortization (2016 - 2024)
BioRestorative Therapies (BRTX) has disclosed Accumulated Depreciation & Amortization for 14 consecutive years, with $1.1 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 9.81% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Dec 2024, up 9.81%, and an annual FY2024 reading of $1.1 million, up 9.81% over the prior year.
- Accumulated Depreciation & Amortization was $1.1 million for Q4 2024 at BioRestorative Therapies, up from $1.0 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $1.1 million in Q4 2024 and bottomed at $878994.0 in Q4 2020.
- Average Accumulated Depreciation & Amortization over 5 years is $966284.8, with a median of $935839.0 recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization grew 1.66% in 2021, then increased 9.81% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $878994.0 in 2020, then grew by 1.66% to $893627.0 in 2021, then increased by 4.72% to $935839.0 in 2022, then rose by 8.12% to $1.0 million in 2023, then rose by 9.81% to $1.1 million in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for BRTX at $1.1 million in Q4 2024, $1.0 million in Q4 2023, and $935839.0 in Q4 2022.